Literature DB >> 27245012

[To explore evidence evaluation for harm: establishing the body of evidence for harm for postmarketing traditional Chinese medicine].

Xing Liao, Yan-ming Xie, Yong-yan Wang, Robinson Nicola.   

Abstract

There has been much difference between effectiveness and harm in evidence evaluation. Many evidence ranking or grading systems have been developed'by researchers in the world. However, no evidence ranking or grading systems are based on safety research reality. Those existing evidence ranking or grading systems are prone to evaluating effectiveness evidence not proper for harm evidence. It is necessary to develop a new system for harm evidence. We put forward to establishing the body of evidence for harm for postmarketing traditional Chinese medicine as required by our daily research work. We do hope such an ideal could be helpful and indicative for evidence evaluation for harm.

Mesh:

Year:  2015        PMID: 27245012

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  To establish a body of evidence on safety for postmarketing Chinese medicine: A new research paradigm.

Authors:  Xing Liao; Yan-Ming Xie; Nicola Robinson; Yong-Yan Wang
Journal:  Chin J Integr Med       Date:  2016-11-29       Impact factor: 1.978

2.  Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine.

Authors:  Ruixue Hu; Su Golder; Guoyan Yang; Xun Li; Di Wang; Liqiong Wang; Ruyu Xia; Nanqi Zhao; Sainan Fang; Baoyong Lai; Jianping Liu; Yutong Fei
Journal:  PLoS One       Date:  2019-11-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.